Skip to main content

Posts

Showing posts from August, 2022

Long Covid----Autoantibodies and immunosuppressants

Post-COVID conditions that last or happen after testing COVID-negative are being referred to by a wide range of names, including long COVID, post-acute COVID-19, long-term effects of COVID, post-acute COVID syndrome, chronic COVID, long-haul COVID, late sequelae, and others, as well as the research term  post-acute sequalae of SARS-COV-2 infection (PASC) Some of the long Covid patients end up having fatigue, memory loss, GI distress, breathing problems, blood abnormalities and other symptoms. There have been reports of low levels of cortisol, primary stress hormone that regulates blood pressure, glucose, sleep/wake cycles, and keeps inflammation down.  Autoantibodies are antibodies that target self-antigens. These antigens may be found in all cell types (e.g. mitochondria, chromatin, centromeres) or be highly specific for a specific cell type of the body (e.g. thyroglobulin in thyroid gland cells).  AutoAbs, especially those that neutralize type I interferons (IFNs), have...